Even with some high-profile hospital deals taking place in the first half of the year, merger activity across the broader healthcare industry has slowed a bit.CVS Health agreed to buy Oak Street Health in a deal worth more than $10 billion, but the pace of healthcare merger activity has slowed…
Source: www.chiefhealthcareexecutive.com – Read more
Wall Street’s Leaders and Laggards of 2024
2024 was a mixed year for biopharma stocks, with the iShares Biotechnology ETF and SPDR S&P Biotech ETF experiencing small decreases. Federal Reserve decisions caused